Dream Labs raises a $90M seed to build general robot intelligence; its Dream-1 World Action Model adapts to new robots zero-shot or with five minutes of data.
We've invested in Ultra, whose Operator robot installs in existing warehouse workstations within hours and has packed over 500,000 e-commerce orders, using real-world deployment data to improve its AI robotics models.
GPU depreciation at hyperscalers isn't about hardware lifespan—it's about accounting timing: chips earn half their lifetime cash in two years but are depreciated evenly over six.
As AI infrastructure scales past GPU constraints, supply chain bottlenecks are shifting to memory, power equipment, and data center land—creating 2027-2028 pricing opportunities the market hasn't yet valued.
Last week, the YC Winter 2023 batch presented their new businesses to an invitation-only group of investors, press, and others in the startup community. The two days included 265 startups, who were selected by YC from a pool of 20,000 applicants.
Find out why hiring top performers is crucial to the growth and success of your startup — and get some tips on how to identify and attract A-players for your team.
Learn from Userflow’s co-founder how the user onboarding app startup beat the odds with bootstrapping and PLG — while enabling PLG for other companies.
Buzzy storytelling startup Tome raises $43M from a who’s who in AI. Do your best work with the latest news and content at Wing.
Wing’s own Sarah Choi was recently interviewed for a profile in Digital Health Business & Technology, where she shared her excitement and predictions for the future of healthtech.
The team at Wing believes deeply in a future that is built on data, powered by AI, and put to work through increasingly autonomous applications.
Sesame Labs is a growth engine for web3 dApps and gives web3 marketers and projects the tools they need to reach, engage, attract, and retain their users and grow their projects in a sustainable way.
Wing co-led Vevo Therapeutics' $12M seed to build the world's largest in vivo atlas—reshaping AI drug discovery by starting with in vivo data.